Cellular regulation and Neoplasm

Review of Normal Cells

  • Plasma (Cell) Membrane: Protective layer separating the cell from its environment.

  • Nucleus and Nucleolus: Control center of the cell containing genetic material; nucleolus produces ribosomes.

  • Structures within the Cytoplasm: Include organelles like rough endoplasmic reticulum, free ribosomes, mitochondria, Golgi complexes, and lysosomes.

Terminology

  • Differentiation: Each cell type undergoes differentiation to perform specific functions; structure reflects tissue function.

  • Mitosis: Part of the cell cycle, requiring genetic control via DNA and RNA.

  • Mutation: Alteration in DNA in parent cell affecting offspring cells.

  • Apoptosis: Programmed cell death to eliminate unneeded or abnormal cells, controlled by genetic elements.

Cellular Changes

  • Cells adapt their growth and differentiation in response to altered conditions such as hormonal stimulation or environmental stimuli.

  • Disease develops when cell structure and function change to a point where homeostasis cannot be maintained.

Cellular Adaptations

  • Atrophy: Decrease in cell size, leading to reduced tissue mass (e.g., due to insufficient nutrition).

  • Hypertrophy: Increase in cell size, resulting in tissue mass enlargement (e.g., enlarged heart muscle).

  • Hyperplasia: Increased number of cells leading to enlarged tissue mass (e.g., uterus during pregnancy).

  • Metaplasia: Replacement of one mature cell type with another (e.g., lung cells in smokers).

  • Dysplasia: Variation in size and shape of cells within a tissue (e.g., chronic infection).

  • Anaplasia: Presence of undifferentiated cells with variable nuclear and cell structures, often seen in malignant tumors.

  • Neoplasia: "New growth" commonly referred to as tumors, which may be benign or metastatic.

Cell Damage

  • Apoptosis: Normal programmed cell death process.

  • Ischemia: Deficit of oxygen in cells; Hypoxia: Reduced oxygen levels in tissues.

  • Nutritional Deficits: Lead to impaired cellular function.

  • Pyroptosis: Lysis of cells causing surrounding inflammation, commonly triggered by infections.

Types of Cell Damage

  • Physical Damage: Caused by excessive heat/cold, radiation, or mechanical damage.

  • Chemical Toxins: Can be exogenous (from environment) or endogenous (from within the body).

  • Microorganisms: Bacteria and viruses causing cell damage.

  • Abnormal Metabolites: Result from genetic disorders affecting metabolism.

Necrosis and Types

  • Necrosis: Dying cells causing further cell damage.

  • Liquefaction Necrosis: Dead cells liquify due to enzyme release.

  • Coagulative Necrosis: Alteration or denaturation of cell proteins.

  • Fat Necrosis: Breakdown of fatty tissue into fatty acids.

  • Caseous Necrosis: Thick, yellowish “cheesy” substance formation, indicates tuberculosis infection.

  • Infarction: Area of dead cells due to oxygen deprivation.

  • Gangrene: Necrotic tissue invaded by bacteria.

Study of Cancer (Oncology)

  • Involves diagnosis, treatment, and prevention of tumors.

Neoplasms

  • Characterized by unchecked cellular growth that disregards normal genetic controls.

  • Neoplasms may consist of atypical or immature cells; characteristics depend on the cell type from which they arise.

Tumor Nomenclature

  • Benign Tumors: Named by tissue type plus suffix -oma (e.g., adenoma).

  • Malignant Tumors: Named by tissue type plus suffix -carcinoma (e.g., adenocarcinoma for epithelial tissue); sarcomas for connective tissue tumors.

  • Specific unique malignant tumor names: Hodgkin’s disease, Wilms’ tumor, leukemia.

Differences between Benign and Malignant Tumors

  • Benign tumors are usually well-differentiated, encapsulated, and grow slowly.

  • Malignant tumors are poorly differentiated, infiltrate surrounding tissues, and exhibit rapid growth with potential metastasis.

Characteristics of Malignant Tumors

  • Loss of mitotic control leading to uncontrolled proliferation; no normal organization.

  • May compress local tissues causing necrosis and inflammation, influencing systemic functions.

  • Tumor-induced inflammation often leads to loss of normal cell function, organ integrity, and can result in systemic effects like altered calcium levels.

Warning Signs of Cancer

  1. Unusual bleeding or discharge.

  2. Change in bowel or bladder habits.

  3. Changes in warts or moles.

  4. Persistent sore.

  5. Unexplained weight loss.

  6. Anemia or persistent fatigue.

  7. Recurring cough or hoarseness.

  8. Solid lump anywhere.

Local Effects of Tumors

  • Pain: Often absent initially, increasing as tumor grows.

  • Obstruction: Tumors can compress ducts affecting blood or lymphatic flow, causing functional damage in organs (e.g., digestive, pulmonary).

Systemic Effects of Malignant Tumors

  • Weight loss, cachexia (muscle wasting), anemia.

  • Physiological stress through increased demands on the body;

  • Fluid buildup leading to effusions, infections, and bleeding.

  • Paraneoplastic syndromes affecting neural and hormonal functions.

Diagnostic Tests for Cancer

  • Routine Screening: Essential for early detection (e.g., breast, testicular exams).

  • Blood Tests: Useful for monitoring cell levels and tumor markers (e.g., PSA test).

  • Imaging: Radiographic techniques, ultrasounds, MRIs, CT scans for visualizing changes in tissues.

  • Biopsy: Necessary to confirm malignancy and determine tumor differentiation.

Spread of Malignant Tumors

  • Local Invasion: Tumor cells invade nearby tissues.

  • Metastasis: Spread to distant sites via the bloodstream or lymphatic system.

Staging Cancer

  • Important for treating and estimating prognosis.

  • Commonly utilizes the TMN system to assess tumor size (T), lymph node involvement (N), and metastasis (M).

Carcinogenesis

  • The process transforming normal cells into cancer cells, influenced by environmental factors, genetic changes, and some infections.

Stages in Carcinogenesis

  • Initiation: First irreversible change in cellular DNA by carcinogens (e.g., radiation, chemicals).

  • Promotion: Hormones, chemicals causing further changes leading to tumor development.

Risk Factors for Cancer

  • Genetic Factors: Oncogenes affecting growth (e.g., breast cancer).

  • Viruses: Examples include hepatitis and HPV increasing risk of liver and cervical cancers respectively.

  • Radiation: Increases skin cancer risk.

  • Chemicals: Hazardous exposure increasing risks for various cancers (e.g., lung cancer from asbestos).

Risk Reduction Strategies

  • Limit UV exposure, regular medical screenings, and maintain a healthy diet rich in antioxidants.

Treatment of Cancer

  • Tailored based on cancer type; options include surgery, chemotherapy, immunotherapy, and radiation.

Examples of Malignant Tumors

  • Skin cancer: Easily diagnosed and treated, but malignant melanoma has a poor prognosis.

  • Ovarian cancer: Poor prognosis due to late detection.

  • Brain tumors: Both benign and malignant tumors pose life-threatening risks.

Disorders of White Blood Cells (WBCs)

  • Key players in inflammation and immune response; normal range is 5,000 to 10,000/mm3.

  • Leukopenia: Decreased WBC levels.

  • Leukocytosis: Increased WBC levels.

Lymphomas

  • Cancers impacting the lymphatic system, categorized mainly into Hodgkin's and non-Hodgkin's lymphoma.

Hodgkin’s Lymphoma Characteristics

  • Presence of Reed-Sternberg cells; most common in upper body lymph nodes, highly treatable.

Staging of Hodgkin’s Lymphoma

  • Four stages ranging from localized to widespread disease, including recurrence post-treatment.

Clinical Manifestations of Hodgkin’s Lymphoma

  • Symptoms include painless enlarged nodes, weight loss, difficulty breathing, fever, night sweats, and more.

Diagnosis & Treatment of Hodgkin’s Lymphoma

  • Diagnosis via physical exams and biopsies; treatment typically involves chemotherapy, radiation, and possible surgery.

Non-Hodgkin’s Lymphoma

  • More common than Hodgkin's, generally worse prognosis; can originate from B or T cells without the presence of Reed-Sternberg cells.

Multiple Myeloma Details

  • Plasma cell cancer characterized by excess of abnormal plasma cells; leads to bone destruction and often advanced diagnosis.

Multiple Myeloma Symptoms

  • Insidious onset; includes anemia, bone pain, and complications like hypercalcemia.

Diagnosis and Treatment of Multiple Myeloma

  • Involves blood tests, biopsies, and imaging; treated with chemotherapy and managing complications.

Leukemia Overview

  • Cancer of the leukocytes characterized by rapid proliferation, crowding out normal blood cells.

Types of Leukemia

  • Acute Lymphoblastic Leukemia (ALL): Primarily in children, good prognosis.

  • Acute Myeloid Leukemia (AML): More common in adults, slightly worse prognosis.

  • Chronic Lymphoid Leukemia (CLL): Primarily adults, managed but not easily treated.

  • Chronic Myeloid Leukemia (CML): Primarily adults, forecast improved with bone marrow transplant.

Clinical Manifestations of Leukemia

  • Includes leukopenia, anemia, thrombocytopenia, and central nervous system dysfunctions.

Diagnosis and Treatment of Leukemia

  • Diagnosis via blood smears and bone marrow biopsy; treated mainly with chemotherapy.

Anemias Overview

  • Result from a decrease in erythrocytes or hemoglobin affecting oxygen transport.

Iron-Deficiency Anemia Details

  • Common due to various factors like inadequate dietary intake or absorption; characterized by symptoms like fatigue and brittle nails.

Pernicious Anemia

  • Vitamin B12 deficiency due to lack of intrinsic factor, affects DNA synthesis and leads to serious symptoms.

Aplastic Anemia Overview

  • Represents bone marrow depression, affecting all blood cells and resulting in symptoms of anemia, leukopenia, and thrombocytopenia.

Hemolytic Anemia Overview

  • Characterized by excessive erythrocyte destruction; includes disorders like sickle cell anemia and thalassemia.

Sickle Cell Anemia Specifics

  • Resulting from abnormal hemoglobin that leads to shaped RBCs causing pain and ischemia.

Forms of Sickle Cell Anemia

  • Trait: Heterozygous, less than half sickled.

  • Disease: Homozygous, severe symptoms.

Sickle Cell Anemia Management and Treatment

  • No cure, focus on management strategies; oxygen therapy, hydration, and pain management are critical.

Thalassemia Overview

  • Abnormal hemoglobin resulting from a genetic lack of globin proteins; common in Mediterranean, Asian, and Indian populations.

Polycysthemia Vera Details

  • Neoplastic condition resulting in excessive erythrocytes and increased blood viscosity; potential complications include thrombosis.

Manifestations of Polycythemia Vera

  • Symptoms may include cyanotic skin, hypertension, and headaches.

Disorders of Platelets Overview

  • Normal platelet levels range from 150,000 to 350,000 mm3.

  • Thrombocytosis: Increased levels; Thrombocytopenia: Decreased levels impacting clotting mechanisms.

Hemophilia A Specifics

  • X-linked recessive disorder characterized by a deficiency of clotting factor VIII.

Thrombophilia Overview

  • Condition predisposing to abnormal clotting, potentially leading to severe conditions like DVT or PE.